See more : DiGiSPICE Technologies Limited (DIGISPICE.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Pets at Home Group Plc (PAHGF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Pets at Home Group Plc, a leading company in the Specialty Retail industry within the Consumer Cyclical sector.
- I G Petrochemicals Limited (IGPL.NS) Income Statement Analysis – Financial Results
- Fanli Digital Technology Co.,Ltd (600228.SS) Income Statement Analysis – Financial Results
- China Financial International Investments Limited (0721.HK) Income Statement Analysis – Financial Results
- Migao Grp Hldg Ltd (9879.HK) Income Statement Analysis – Financial Results
- Guangzhou R&F Properties Co., Ltd. (2777.HK) Income Statement Analysis – Financial Results
Pets at Home Group Plc (PAHGF)
About Pets at Home Group Plc
Pets at Home Group Plc engages in the specialist omnichannel retailing of pet food, pet related products, and pet accessories in the United Kingdom. It operates through three segments: Retail, Vet Group, and Central. The company offers a range of pet foods for dogs, cats, small animals, fish, reptiles, and birds. It also provides pet accessories, including cat litters, collars, leads and harnesses, bedding, housing, feeding, health and hygiene, travel, training, and enrichment products. In addition, the company offers pet grooming services comprising a full groom, bath and brush, microchipping, and nail clipping; and pet insurance products. Further, it operates First Opinion veterinary practices that provides pet healthcare advice services; and provides veterinary telehealth services. The company operates through 452 stores, 441 practices, and 316 grooming salons. It also provides products and services through online. Pets at Home Group Plc was founded in 1991 and is based in Handforth, the United Kingdom.
Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.48B | 1.40B | 1.32B | 1.14B | 1.06B | 961.04M | 898.92M | 834.17M | 793.13M | 729.09M | 665.40M | 598.34M | 544.33M | 517.83M |
Cost of Revenue | 785.30M | 735.90M | 669.80M | 583.40M | 547.50M | 514.50M | 434.32M | 382.29M | 360.70M | 333.78M | 307.27M | 274.36M | 252.02M | 242.35M |
Gross Profit | 691.30M | 668.30M | 648.00M | 559.40M | 511.30M | 446.54M | 464.61M | 451.88M | 432.42M | 395.31M | 358.12M | 323.98M | 292.31M | 275.48M |
Gross Profit Ratio | 46.82% | 47.59% | 49.17% | 48.95% | 48.29% | 46.46% | 51.68% | 54.17% | 54.52% | 54.22% | 53.82% | 54.15% | 53.70% | 53.20% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 121.10M | 123.80M | 121.20M | 131.90M | 92.80M | 79.28M | 66.32M | 54.95M | 50.87M | 40.70M | 34.82M | 29.82M | 26.23M | 21.22M |
Selling & Marketing | 463.60M | 419.90M | 382.20M | 321.00M | 313.80M | 314.40M | 309.48M | 296.01M | 279.29M | 257.85M | 233.89M | 215.18M | 192.81M | 177.00M |
SG&A | 584.70M | 543.70M | 503.40M | 452.90M | 406.60M | 393.69M | 375.81M | 350.96M | 330.16M | 298.55M | 268.71M | 244.99M | 219.05M | 198.22M |
Other Expenses | -38.90M | 0.00 | 0.00 | 0.00 | -6.90M | -22.50M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 545.80M | 531.50M | 503.40M | 452.90M | 406.60M | 393.69M | 375.81M | 350.96M | 330.16M | 298.55M | 268.71M | 244.99M | 219.05M | 198.22M |
Cost & Expenses | 1.33B | 1.27B | 1.17B | 1.04B | 954.10M | 908.19M | 810.12M | 733.25M | 690.86M | 632.32M | 575.98M | 519.35M | 471.06M | 440.57M |
Interest Income | 4.00M | 2.70M | 200.00K | 400.00K | 600.00K | 577.00K | 685.00K | 760.00K | 668.00K | 572.00K | 368.00K | 388.00K | 310.00K | 166.00K |
Interest Expense | 17.60M | 17.00M | 14.60M | 18.80M | 18.40M | 4.11M | 4.96M | 5.30M | 5.63M | 10.37M | 32.26M | 33.56M | 41.74M | 41.54M |
Depreciation & Amortization | 109.60M | 102.30M | 103.90M | 105.40M | 109.40M | 36.82M | 34.48M | 29.62M | 25.11M | 22.84M | 19.99M | 18.21M | 15.65M | 14.05M |
EBITDA | 232.90M | 241.80M | 267.90M | 230.40M | 213.60M | 90.53M | 119.04M | 130.31M | 127.20M | 120.17M | 80.04M | 84.20M | 89.22M | 89.72M |
EBITDA Ratio | 15.77% | 17.30% | 18.82% | 19.05% | 20.28% | 9.39% | 13.79% | 15.74% | 16.14% | 16.48% | 15.70% | 15.34% | 15.25% | 16.61% |
Operating Income | 145.50M | 136.80M | 163.80M | 134.80M | 103.70M | 53.14M | 83.87M | 99.92M | 101.43M | 96.76M | 78.84M | 73.07M | 73.26M | 75.50M |
Operating Income Ratio | 9.85% | 9.74% | 12.43% | 11.80% | 9.79% | 5.53% | 9.33% | 11.98% | 12.79% | 13.27% | 11.85% | 12.21% | 13.46% | 14.58% |
Total Other Income/Expenses | -39.80M | -14.30M | -15.10M | -18.40M | -17.80M | -3.50M | -4.28M | -4.54M | -9.29M | -9.80M | -56.34M | -52.47M | -47.62M | -48.47M |
Income Before Tax | 105.70M | 122.50M | 148.70M | 116.40M | 85.90M | 49.60M | 79.60M | 95.38M | 92.14M | 86.97M | 22.51M | 26.65M | 25.65M | 28.64M |
Income Before Tax Ratio | 7.16% | 8.72% | 11.28% | 10.19% | 8.11% | 5.16% | 8.85% | 11.43% | 11.62% | 11.93% | 3.38% | 4.45% | 4.71% | 5.53% |
Income Tax Expense | 26.50M | 21.80M | 24.20M | 17.40M | 18.50M | 19.11M | 16.78M | 20.02M | 19.36M | 14.79M | 8.96M | 5.89M | -3.51M | 9.32M |
Net Income | 79.20M | 100.70M | 124.50M | 90.40M | 67.40M | 30.49M | 62.81M | 75.36M | 72.78M | 72.17M | 13.55M | 20.75M | 22.26M | 14.69M |
Net Income Ratio | 5.36% | 7.17% | 9.45% | 7.91% | 6.37% | 3.17% | 6.99% | 9.03% | 9.18% | 9.90% | 2.04% | 3.47% | 4.09% | 2.84% |
EPS | 0.16 | 0.21 | 0.25 | 0.18 | 0.14 | 0.06 | 0.13 | 0.15 | 0.15 | 0.14 | -0.05 | -0.05 | 0.04 | 0.03 |
EPS Diluted | 0.16 | 0.21 | 0.25 | 0.18 | 0.13 | 0.06 | 0.13 | 0.15 | 0.14 | 0.14 | -0.05 | -0.05 | 0.04 | 0.03 |
Weighted Avg Shares Out | 482.93M | 501.11M | 501.11M | 501.11M | 501.11M | 501.11M | 501.11M | 501.11M | 501.11M | 501.11M | 501.11M | 501.11M | 501.11M | 501.11M |
Weighted Avg Shares Out (Dil) | 482.70M | 501.11M | 501.11M | 501.11M | 501.11M | 501.11M | 501.11M | 501.11M | 501.11M | 501.11M | 501.11M | 501.11M | 501.11M | 501.11M |
CVS offers solution to CMA as Pets at Home bats off probe concerns
Pets At Home Not The Cat's Whiskers As Subpar Sales Spur Guidance Cut
Pets at Home issues profit warning on weaker retail spend
Can Pets at Home reap the rewards of a digital push?
Pets at Home share price is cheap and could be acquired – report
Pets at Home unscathed after first half of huge risks
Rolls-Royce, easyJet, Pets at Home and more: Tuesday preview
Pets at Home to be the good boy or bad dog in half-year results?
Pets at Home suffers "operational hiccups" as vet probe looms
Pets at Home “not the target” of vet probe - analyst
Source: https://incomestatements.info
Category: Stock Reports